Literature DB >> 12614978

Leptin: metabolic control and regulation.

Darleen A Sandoval1, Stephen N Davis.   

Abstract

Leptin, a protein released from adipose tissue, is being recognized to play an integral role in endocrine regulation of metabolism. While it is clearly evident that leptin is decreased during caloric restriction, the response of leptin to other types of stress has been plagued by conflicting data. With hypoglycemia stress, the literature may conflict because experimentally hypoglycemia is induced with infusion of insulin, an endocrine factor that can increase leptin levels. With exercise, leptin's response may depend on duration and intensity of exercise. While it has been clearly shown that the sympathetic nervous system (SNS) inhibits leptin secretion in a variety of experimental modes, the hypothalamic-pituitary-adrenal (HPA) axis may stimulate leptin secretion. This creates a paradox of leptin regulation during stress since both systems are activated with stress. If the SNS inhibition overrides the HPA axis' activation of leptin secretion, leptin's role during stress may be to allow a shifting of fuel consumption towards carbohydrate utilization. In type 1 diabetes mellitus, autonomic dysfunction may prevent the fall in leptin during stress. Although obesity is associated with type 2 diabetes mellitus, patients may have decreased leptin levels, especially when glucose is poorly controlled. This may contribute to further obesity and worsening of the disease. The purpose of this review to is critically analyze the literature regarding the impact of different types of stress on leptin secretion, the function of leptin during stress, and the role of leptin in the pathophysiology of diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614978     DOI: 10.1016/s1056-8727(02)00167-8

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  30 in total

1.  Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.

Authors:  Shehab M Abd El-Kader; Fadwa M Al-Shreef; Osama H Al-Jiffri
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

2.  Satietogenic Protein from Tamarind Seeds Decreases Food Intake, Leptin Plasma and CCK-1r Gene Expression in Obese Wistar Rats.

Authors:  Izael S Costa; Amanda F Medeiros; Fabiana M C Carvalho; Vanessa C O Lima; Raphael P Serquiz; Alexandre C Serquiz; Vivian N Silbiger; Raul H Bortolin; Bruna L L Maciel; Elizeu A Santos; Ana H A Morais
Journal:  Obes Facts       Date:  2018-12-11       Impact factor: 3.942

3.  Leptin and its association with somatic depressive symptoms in patients with the metabolic syndrome.

Authors:  Diana A Chirinos; Ronald Goldberg; Marc Gellman; Armando J Mendez; Miriam Gutt; Judith R McCalla; Maria M Llabre; Neil Schneiderman
Journal:  Ann Behav Med       Date:  2013-08

4.  Psychological wellbeing and biochemical modulation in response to weight loss in obese type 2 diabetes patients.

Authors:  Al-Jiffri Osama; Abd El-Kader Shehab
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

5.  Inhaled ozone (O3)-induces changes in serum metabolomic and liver transcriptomic profiles in rats.

Authors:  Desinia B Miller; Edward D Karoly; Jan C Jones; William O Ward; Beena D Vallanat; Debora L Andrews; Mette C Schladweiler; Samantha J Snow; Virginia L Bass; Judy E Richards; Andrew J Ghio; Wayne E Cascio; Allen D Ledbetter; Urmila P Kodavanti
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-31       Impact factor: 4.219

6.  Comparative Intracerebroventricular and Intrathecal Administration of a Nanomolar Macrocyclic Melanocortin Receptor Agonist MDE6-5-2c (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro]) Decreases Food Intake in Mice.

Authors:  Danielle N Adank; Mary M Lunzer; Mark D Ericson; Zoe M Koeperich; Stacey L Wilber; Katlyn A Fleming; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2020-09-10       Impact factor: 4.418

7.  Early neuroendocrine alterations in female rats following a diet moderately enriched in fat.

Authors:  George Soulis; Efthimia Kitraki; Kyriaki Gerozissis
Journal:  Cell Mol Neurobiol       Date:  2005-08       Impact factor: 5.046

8.  Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients.

Authors:  Gilberto Paz-Filho; Karin Esposito; Barry Hurwitz; Anil Sharma; Chuanhui Dong; Victor Andreev; Tuncay Delibasi; Halil Erol; Alejandro Ayala; Ma-Li Wong; Julio Licinio
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

9.  Control of leptin by metabolic state and its regulatory interactions with pituitary growth hormone and hepatic growth hormone receptors and insulin like growth factors in the tilapia (Oreochromis mossambicus).

Authors:  Jonathan D Douros; David A Baltzegar; Jamie Mankiewicz; Jordan Taylor; Yoko Yamaguchi; Darren T Lerner; Andre P Seale; E Gordon Grau; Jason P Breves; Russell J Borski
Journal:  Gen Comp Endocrinol       Date:  2016-07-19       Impact factor: 2.822

10.  Postnatal early overnutrition changes the leptin signalling pathway in the hypothalamic-pituitary-thyroid axis of young and adult rats.

Authors:  Ananda Lages Rodrigues; Egberto Gaspar de Moura; Magna Cottini Fonseca Passos; Sheila Cristina Potente Dutra; Patricia Cristina Lisboa
Journal:  J Physiol       Date:  2009-04-29       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.